HK2 and hepatocellular carcinoma: HK2 was recently identified as a downstream target of ZMYND8 in HCC cells, and high expression of ZMYND8 in HCC was associated with glucose consumption, increased lactate, and ATP production in HCC cells, and was associated with patients with unfavorable clinicopathological features and poor prognosis.